Literature DB >> 18656912

Docking of noncompetitive inhibitors into dengue virus type 2 protease: understanding the interactions with allosteric binding sites.

Rozana Othman1, Tan Siew Kiat, Norzulaani Khalid, Rohana Yusof, E Irene Newhouse, James S Newhouse, Masqudul Alam, Noorsaadah Abdul Rahman.   

Abstract

A group of flavanones and their chalcones, isolated from Boesenbergia rotunda L., were previously reported to show varying degrees of noncompetitive inhibitory activities toward Dengue virus type 2 (Den2) protease. Results obtained from automated docking studies are in agreement with experimental data in which the ligands were shown to bind to sites other than the active site of the protease. The calculated K(i) values are very small, indicating that the ligands bind quite well to the allosteric binding site. Greater inhibition by pinostrobin, compared to the other compounds, can be explained by H-bonding interaction with the backbone carbonyl of Lys74, which is bonded to Asp75 (one of the catalytic triad residues). In addition, structure-activity relationship analysis yields structural information that may be useful for designing more effective therapeutic drugs against dengue virus infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18656912     DOI: 10.1021/ci700388k

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  20 in total

1.  Toward prediction of functional protein pockets using blind docking and pocket search algorithms.

Authors:  Csaba Hetényi; David van der Spoel
Journal:  Protein Sci       Date:  2011-03-30       Impact factor: 6.725

2.  An overview on cardamonin.

Authors:  Luís Moreira Gonçalves; Inês Maria Valente; José António Rodrigues
Journal:  J Med Food       Date:  2014-01-16       Impact factor: 2.786

3.  The Utility of the HSAB Principle via the Fukui Function in Biological Systems.

Authors:  John Faver; Kenneth M Merz
Journal:  J Chem Theory Comput       Date:  2010-02-09       Impact factor: 6.006

4.  Identification of new potent inhibitors of dengue virus NS3 protease from traditional Chinese medicine database.

Authors:  Vivek Dhar Dwivedi; Indra Prasad Tripathi; Shiv Bharadwaj; Aman Chandra Kaushik; Sarad Kumar Mishra
Journal:  Virusdisease       Date:  2016-07-20

5.  Design, structure-based focusing and in silico screening of combinatorial library of peptidomimetic inhibitors of Dengue virus NS2B-NS3 protease.

Authors:  Vladimir Frecer; Stanislav Miertus
Journal:  J Comput Aided Mol Des       Date:  2010-03-21       Impact factor: 3.686

6.  Novel dengue virus NS2B/NS3 protease inhibitors.

Authors:  Hongmei Wu; Stefanie Bock; Mariya Snitko; Thilo Berger; Thomas Weidner; Steven Holloway; Manuel Kanitz; Wibke E Diederich; Holger Steuber; Christof Walter; Daniela Hofmann; Benedikt Weißbrich; Ralf Spannaus; Eliana G Acosta; Ralf Bartenschlager; Bernd Engels; Tanja Schirmeister; Jochen Bodem
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

7.  Serotype-specific structural differences in the protease-cofactor complexes of the dengue virus family.

Authors:  Sumana Chandramouli; Jeremiah S Joseph; Sophie Daudenarde; Jovylyn Gatchalian; Cromwell Cornillez-Ty; Peter Kuhn
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

8.  Social sciences research in neglected tropical diseases 2: A bibliographic analysis.

Authors:  Daniel D Reidpath; Pascale Allotey; Subhash Pokhrel
Journal:  Health Res Policy Syst       Date:  2011-01-06

9.  Efficacy of Boesenbergia rotunda Treatment against Thioacetamide-Induced Liver Cirrhosis in a Rat Model.

Authors:  Suzy M Salama; Mehmet Bilgen; Ahmed S Al Rashdi; Mahmood A Abdulla
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-04       Impact factor: 2.629

10.  Boesenbergia rotunda: From Ethnomedicine to Drug Discovery.

Authors:  Tan Eng-Chong; Lee Yean-Kee; Chee Chin-Fei; Heh Choon-Han; Wong Sher-Ming; Christina Thio Li-Ping; Foo Gen-Teck; Norzulaani Khalid; Noorsaadah Abd Rahman; Saiful Anuar Karsani; Shatrah Othman; Rozana Othman; Rohana Yusof
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.